Compare Immunovant Inc. Common Stock (IMVT) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 3.8× Immunovant Inc. Common Stock's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| IMVT | ROIV | |
|---|---|---|
Market Cap | $6.62B | $25.09B |
Volume | 1,131,364 | 5,738,571 |
Sector | Health | Health |
52-Week High | $44.96 | $41.81 |
52-Week Low | $17.03 | $16.04 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $21.36B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
